Balancing the risks of bleeding and ischaemia in myocardial infarction patients at high bleeding risk
Eur Heart J Cardiovasc Pharmacother
.
2023 Dec 14;9(8):770-771.
doi: 10.1093/ehjcvp/pvad068.
Authors
J Tjerkaski
1
,
T Jernberg
1
,
K Szummer
2
Affiliations
1
Department of Clinical Sciences, Danderyd University Hospital, Karolinska Institute, Stockholm 182 88, Sweden.
2
Section of Cardiology, Department of Medicine, Karolinska Institutet, Huddinge, Stockholm 171 77, Sweden.
PMID:
37740444
PMCID:
PMC10719447
DOI:
10.1093/ehjcvp/pvad068
No abstract available
Publication types
Editorial
Comment
Grants and funding
Bayer
Vifor Pharma